Misonix (NSDQ:MSON) said yesterday that it put $97 million in stock on the table for Solsys Medical, formerly Soluble Systems, and its TheraSkin regenerative wound dressing. The deal calls for Farmingdale, N.Y.-based Misonix to issue 5.7 million new shares to Solsys stockholders, which would leave MSON investors owning 64% of the new company and former Solsys […]
Wound care company Soluble Systems wrapped up a $3.5 million private equity funding round, raising most of the cash from existing company insiders, board members and executives.
Of the total 57 investors, only 10 are 1st-timers and the remaining are current stakeholders who chose to up the ante in the most recent round. None of the new cash came from venture capital firms, the company told MassDevice.com.